Cargando…
Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease
INTRODUCTION: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with primary sclerosing cholangitis (PSC) suggests a relation between the gut and the liver in patients with both PSC and IBD. One hypothesis suggests that aberrantly expressed homing molecules in the liver...
Autores principales: | de Krijger, Manon, Visseren, Thijmen, Wildenberg, Manon E., Hooijer, Gerrit K.J., Verstegen, Monique M.A., van der Laan, Luc J.W., de Jonge, Wouter J., Verheij, Joanne, Ponsioen, Cyriel Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388383/ https://www.ncbi.nlm.nih.gov/pubmed/32743534 http://dx.doi.org/10.1016/j.jtauto.2020.100054 |
Ejemplares similares
-
Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
por: de Krijger, Manon, et al.
Publicado: (2022) -
Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
por: de Krijger, Manon, et al.
Publicado: (2022) -
Primary Sclerosing Cholangitis–Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity
por: Kamp, Eline J.C.A., et al.
Publicado: (2021) -
Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis
por: Kamp, Eline JCA, et al.
Publicado: (2022) -
Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management
por: Milkiewicz, Piotr, et al.
Publicado: (2020)